Loading
ABL Europe
  • Home
  • GMP manufacturing
  • Hosting services
    • Hosting services
    • Resident companies
  • About
    • Our team
    • About us
    • Our values
    • Our facilities
    • News & Events
      • News
      • Events
  • Careers
  • Contact
  • Search
  • News

June 08, 2017 : A major step in the restoration of Gut Microbiota : MaaT Pharma and Biocodex to industrialize FMT & develop an oral formulation

8 May 2017/0 Comments/in News /by Typhaine DEROBERT
Read more →

April, 13th 2017 : Workshop StartCluster at Accinov

4 April 2017/0 Comments/in News /by Typhaine DEROBERT
Read more →

March, 2017 : What’s new by Accinov ?

3 April 2017/0 Comments/in News /by Typhaine DEROBERT
Read more →

March 17, 2017 : Accinov use IVTracer by Netceler for its environmental monitoring – Discover our user experience in video

5 March 2017/0 Comments/in News /by Typhaine DEROBERT
Read more →

February 02, 2017 Louis Schweitzer, Commissaire Général à l’Investissement, visits Maat Pharma at Accinov.

23 January 2017/0 Comments/in News /by Typhaine DEROBERT
Read more →
Page 3 of 6‹12345›»

News & Events

  • November 19, 2018: ABL Expands GMP Viral Vector Manufacturing Capacity with State-of-the-Art Facility Acquisition in Lyon, France
  • June 20, 2018: ABL EUROPE,THE PURCHASER OF ACCINOV
  • February 2018: ABL Europe Enters into a Collaboration for the GMP Manufacture of Hookipa Biotech’s Heterologous Viral Vector Immunotherapy Platform
  • January 2018: SillaJen and ABL Europe Expand Strategic Manufacturing Collaboration for Oncolytic Virus Therapies
  • January 2018: ABL EUROPE’S GMP MANUFACTURING FACILITY FOR VIRAL VECTOR PRODUCTION: SARTORIUS STEDIM

ABL Europe

Headquarter
4 Rue Laurent Fries,
67400 Illkirch-Graffenstaden
Phone: +33 3 88 55 10 00

Lyon Site
317, avenue Jean Jaurès,
FRANCE - 69007 LYON
Phone: +33 (0)4 37 28 73 00

Subscribe to our newsletter

© Copyright ABL Europe 2018    -    credit: Viewbox

Follow us:

 
Scroll to top